Senior Specialist, Drug Safety CRISPR TherapeuticsSenior Specialist, Drug SafetySouth Boston, MassachusettsThe Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. The Company continues to expand its leadership in gene editing through the development of SyNTase editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction.
Senior Specialist, Drug Safety CRISPR Therapeutics AGSenior Specialist, Drug SafetySouth Boston, MA$105,000–$115,000 / yearThe Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY (exagamglogene autotemcel [exa-cel]), the world's first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. The Company continues to expand its leadership in gene editing through the development of SyNTase editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction.
Medical Director, Global Drug Safety Replimune Group IncMedical Director, Global Drug SafetyWoburn, MA$257,500–$333,500 / yearThe RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient's lives depend on it.
Project Toxicologist, Director - Oncology Targeted Delivery (OTD) Safety Science, Clinical Pharmacology and Safety Sciences (Cambridge, MA or Gaithersburg, MD) AstraZeneca PlcProject Toxicologist, Director - Oncology Targeted Delivery (OTD) Safety Science, Clinical Pharmacology and Safety Sciences (Cambridge, MA or Gaithersburg, MD)Cambridge, MA$184,538–$276,808 / yearAlternative experience pathway: Candidates with a minimum bachelor's degree and substantial additional pharmaceutical industry experience may also be considered, including candidates with approximately 15 or more years of relevant experience. Professional experience: Typically, at least 10 years of experience in project toxicology, investigative toxicology, regulatory toxicology, or related safety-focused roles within the pharmaceutical, biotechnology, or CRO sector.
Global Safety Lead - Formulation Safety CSL Behring LLCGlobal Safety Lead - Formulation SafetyWaltham, MAOversees analysis of aggregate safety data and the production of key company documents such as DSURs (Development Safety Update Reports), PSURs (Periodic Safety Update Reports) and risk management plans relating to the safety of medicinal products, which are subject to regulatory review and discussion. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
Global Safety Lead - Formulation Safety CSL PlasmaGlobal Safety Lead - Formulation SafetyWaltham, PennsylvaniaOversees analysis of aggregate safety data and the production of key company documents such as DSURs (Development Safety Update Reports), PSURs (Periodic Safety Update Reports) and risk management plans relating to the safety of medicinal products, which are subject to regulatory review and discussion. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
Executive Director, Global Regulatory Affairs CMC Devices and Drug-Device Combination Product 3316 Takeda Development Center AmericasExecutive Director, Global Regulatory Affairs CMC Devices and Drug-Device Combination ProductBoston, MassachusettsAs Executive Director, Global Regulatory Affairs CMC Devices and Drug-Device Combination Product, you will provide strategic leadership and development to global regulatory subject matter experts to ensure innovative and robust regulatory strategies for medical devices and drug-device combination products, maximizing global regulatory success and minimizing time to approval/clearance. Leads and develops a team of regulatory leaders and subject matter experts, overseeing global regulatory strategy and major submissions for an assigned portfolio of medical devices and drug-device combination products, ensuring clear strategy, high-quality execution, and timely approvals/clearances.
Senior Associate Scientist - Drug Product Development SanofiSenior Associate Scientist - Drug Product DevelopmentCambridge, MA$75–$108.33 / hourThe successful candidate will contribute to the design, development, and optimization of preclinical formulations (conventional and enabling) and clinical solid oral dosage forms (tablet and capsule), from early-stage development through scale-up and technology transfer to GMP manufacturing. Education: Bachelor's degree OR Master's degree in Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biomedical Engineering, Materials Science, Food Science, or a related life science/scientific/engineering discipline.
VP, Head Of Drug Discovery Relay Therapeutics, Inc.VP, Head Of Drug DiscoveryCambridge, MA$230,000–$328,000 / yearBuilt on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. This individual will be responsible for driving the discovery and optimization of transformative small molecule therapeutics by building a highly collaborative, data-driven discovery engine that combines deep scientific expertise with modern computational approaches.
NewPrincipal Scientist - Drug Discovery (Diabetes) Novo Nordisk ASPrincipal Scientist - Drug Discovery (Diabetes)Waltham, MA$185,000–$230,000 / yearInternal relationships include working closely with technical staff & other members of the scientific leadership team; regular collaborations with members of other research departments at Novo Nordisk; & frequent interaction with project managers & other colleagues across global R&D. With your translational mindset and background within Diabetes and metabolic disease, you will be responsible for the establishment and utilization of relevant molecular approaches, cellular assays, and read-outs in order to investigate the mode-of-action of novel drug candidates and to progress our research projects.
Senior Director, Novel Drug Delivery Technologies Eli Lilly and CompanySenior Director, Novel Drug Delivery TechnologiesMassachusettsOur current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL). The Drug Delivery group at Lilly studies physiological barriers across routes of administration to create novel, patient-centric delivery solutions, serving as a center of excellence in injection physiology, device ideation, novel drug delivery technologies across modalities and routes of administration, nanomedicine and targeted delivery, and connected devices/digital biomarkers.
Senior Director, Focused Ultrasound Drug Delivery Eli Lilly and CompanySenior Director, Focused Ultrasound Drug DeliveryBoston, MA$166,500–$264,000 / yearThis role anchors a growing technical capability in ultrasound-mediated delivery - spanning focused ultrasound (FUS) for deep-tissue and organ-specific targets as well as non-focused ultrasound approaches where spatial precision is not required for the target bioeffect - including microbubble/nanobubble-mediated bioeffects such as sonoporation and reversible barrier permeabilization, intended to enhance delivery of biologics and gene therapies across a range of deep and superficial tissue targets and emerging routes of administration. Job Position Overview: The Drug Delivery group at Lilly studies physiological barriers across routes of administration to create novel, patient-centric delivery solutions, serving as a center of excellence in injection physiology, device ideation, novel drug delivery technologies across modalities and routes of administration, nanomedicine and targeted delivery, and connected devices/digital biomarkers.
NewDrug Trend Management Pipeline Development Senior Manager Devoted Health ServicesDrug Trend Management Pipeline Development Senior ManagerMassachusettsRemoteThe actual base salary offered will depend on a variety of factors, including the qualifications of the individual applicant for the position, years of relevant experience, specific and unique skills, level of education attained, certifications or other professional licenses held, and the location in which the applicant lives and/or from which they will be performing the job. As the Drug Trend Management Pipeline Development Senior Manager, you work a standing book of drug cost, safety, and integrity opportunities across Part B and Part D. Every item in it is a pattern across a group of members, and your job is to dig in and figure out which ones are worth solving for.
Drug Product MSAT Scientist I Thermo Fisher Scientific IncDrug Product MSAT Scientist IPlainville, MA$25.60–$38.39 / hourWe provide our global teams with the resources needed to achieve individual career goals while helping to take science a step beyond by developing solutions for some of the world's toughest challenges, like protecting the environment, making sure our food is safe or helping find cures for cancer. At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy.
Drug Substance MSAT Scientist II Thermo Fisher ScientificDrug Substance MSAT Scientist IIPlainville, MassachusettsWe provide our global teams with the resources needed to achieve individual career goals while helping to take science a step beyond by developing solutions for some of the world’s toughest challenges, like protecting the environment, making sure our food is safe or helping find cures for cancer. At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy.
Drug Product MSAT Scientist II Thermo Fisher Scientific IncDrug Product MSAT Scientist IIMA$66,000–$99,000 / yearWe provide our global teams with the resources needed to achieve individual career goals while helping to take science a step beyond by developing solutions for some of the world's toughest challenges, like protecting the environment, making sure our food is safe or helping find cures for cancer. At least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy.
VP, Head of Drug Discovery Relay Therapeutics IncVP, Head of Drug DiscoveryCambridge, MA$230,000–$328,000 / yearBuilt on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. This individual will be responsible for driving the discovery and optimization of transformative small molecule therapeutics by building a highly collaborative, data-driven discovery engine that combines deep scientific expertise with modern computational approaches.
Small Molecule Drug Substance Lead GSK, Plc.Small Molecule Drug Substance LeadWaltham, MA$149,325–$248,875 / yearPlease note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK.
Director/Senior Director, CMC Drug Substance Development Enanta PharmaceuticalsDirector/Senior Director, CMC Drug Substance DevelopmentWatertown, MA$173,000–$285,333 / yearEnanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT, STAT6 and MRGPRX2 inhibition. Select and Oversee External Partners : Screen, select, and manage global external partners for process research, non-GMP production, GMP production, tech transfer, validation, and drug substance manufacturing activities.
VP, Head of Drug Discovery Relay TherapeuticsVP, Head of Drug DiscoveryCambridge, MA$230,000–$328,000 / yearBuilt on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. This individual will be responsible for driving the discovery and optimization of transformative small molecule therapeutics by building a highly collaborative, data-driven discovery engine that combines deep scientific expertise with modern computational approaches.